Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.

Journal of Alzheimer's disease : JAD - 1 Jan 2015

Waring Jeffrey F, Tang Qi, Robieson Weining Z, King David P, Das Ujjwal, Dubow Jordan, Dutta Sandeep, Marek Gerard J, Gault Laura M

Abstract excerpt

BACKGROUND: Previous studies have investigated associations between apolipoprotein E (APOE)-ɛ4 allele status and acetylcholinesterase inhibitor treatment response in patients with Alzheimer's disease. The ability to draw definitive conclusions regarding the effect of APOE-ɛ4 genotype on treatment response has been hindered by inconsistent results among studies and methodological limitations that restrict...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein E4
Share to Cholinesterase Inhibitors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cognition

Share to Double-Blind Method

Share to Indans

Share to Neuropsychological Tests

Share to Piperidines

Share to Psychiatric Status Rating Scales

Source

Open in PubMed Open full text

Identifiers

PMID: 26402762
DOI: 10.3233/JAD-142589
PMCID: PMC4923746

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer's Disease.PMID 26402762Read ↗

Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Effect of ApoE genotype on response to donepezil in patients with Alzheimer's disease.Semantic proximity Read ↗

Effect of the CYP2D6 and APOE Polymorphisms on the Efficacy of Donepezil in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

APOE genotyping and response to drug treatment in Alzheimer's disease.Semantic proximity Read ↗

The APOE genotype: modification of therapeutic responses in Alzheimer's disease.Semantic proximity Read ↗

Presence or absence of at least one epsilon 4 allele and gender are not predictive for the response to donepezil treatment in Alzheimer's disease.Semantic proximity Read ↗

Response to rivastigmine transdermal patch or memantine plus rivastigmine patch is affected by apolipoprotein E genotype in Alzheimer patients.Semantic proximity Read ↗

Metrifonate treatment of AD: influence of APOE genotype.Semantic proximity Read ↗

Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis.Semantic proximity Read ↗

Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's diseaseSemantic proximity Read ↗

Deleterious Effect of Butyrylcholinesterase K-Variant in Donepezil Treatment of Mild Cognitive Impairment.Semantic proximity Read ↗

Influence of rs1080985 single nucleotide polymorphism of the CYP2D6 gene on response to treatment with donepezil in patients with Alzheimer&rsquo;s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.